MorphoSys Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Constellation Pharmaceuticals phoenixherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phoenixherald.com Daily Mail and Mail on Sunday newspapers.
MorphoSys Commences Cash Tender Offer for All Outstanding Shares of Constellation Pharmaceuticals
ACCESSWIRE
17 Jun 2021, 08:31 GMT+10
PLANEGG, GERMANY / ACCESSWIRE / June 16, 2021 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) ( MorphoSys ) today announced that it is commencing a cash tender offer to purchase all outstanding shares of Constellation Pharmaceuticals, Inc., (CNST) ( Constellation ) for $34.00 per share, net to the seller in cash, without interest, and subject to any applicable withholding of taxes. The tender offer is being made pursuant to the previously announced merger agreement, dated June 2, 2021 between MorphoSys and Constellation.
The tender offer is scheduled to expire at one minute past 11:59 p.m. New York City Time, on July 14, 2021, unless extended or earlier terminated, in each case in accordance with the terms of the merger agreement. The tender offer is subject to various conditions including a minimum tender of at least a majority of outstanding Constellation
MorphoSys Commences Cash Tender Offer for All Outstanding Shares of Constellation Pharmaceuticals MorphoSys AG (FSE: MOR; NASDAQ: MOR) ( MorphoSys ) today announced that it is commencing a cash tender offer to purchase all outstanding shares of Constellation Pharmaceuticals, Inc., (NASDAQ: CNST) ( Constellation ) for $34.00 per share, net to the seller in cash, without interest, and subject to any applicable withholding of taxes. The tender offer is being made pursuant to the previously announced merger agreement, dated June 2, 2021 between MorphoSys and Constellation. The tender offer is scheduled to expire at one minute past 11:59 p.m. New York City Time, on July 14, 2021, unless extended or earlier terminated, in each case in accordance with the terms of the merger agreement. The tender offer is subject to various conditions including a minimum tender of at least a majority of outstanding Constellation shares, the expiration or termination of the
Constellation Pharmaceuticals
DGAP-News: MorphoSys AG / Schlagwort(e): Fusionen & Übernahmen
MorphoSys startet Barangebot für alle ausstehenden Aktien von Constellation
Pharmaceuticals
16.06.2021 / 23:43
Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich.
Medienmitteilung
MorphoSys startet Barangebot für alle ausstehenden Aktien von Constellation
Pharmaceuticals
Die MorphoSys AG (FSE: MOR; NASDAQ: MOR) ( MorphoSys ) gab heute bekannt, dass
sie ein Barangebot zum Erwerb aller ausstehenden Aktien der Constellation
Pharmaceuticals, Inc. (NASDAQ: CNST) ( Constellation ) für 34,00 US-Dollar je
Aktie, netto in bar,
DGAP-News: MorphoSys startet Barangebot für alle ausstehenden Aktien von Constellation Pharmaceuticals boersennews.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from boersennews.de Daily Mail and Mail on Sunday newspapers.